Provide a valuable resource to your clients or customers by linking to this resource page. Just place the following link on your website.
A coagulation analyzer is a laboratory or point-of-care device used to test how blood clots. It can measure clotting times and related values such as PT, INR, aPTT, fibrinogen, D-dimer, or other coagulation markers depending on the system. The analyzer helps clinicians assess bleeding risk, clotting problems, and anticoagulant therapy. Results must be interpreted with the patient’s condition and other laboratory findings.
read more about coagulation analyzer ...A coagulation analyzer is used to evaluate the blood’s clotting function. It may help diagnose bleeding disorders, monitor warfarin or heparin therapy, assess clotting before procedures, or support emergency and critical care decisions. Hospitals, laboratories, anticoagulation clinics, and some bedside settings may use these devices. The exact test menu depends on the analyzer, reagents, and clinical setting.
A blood sample is mixed with reagents that trigger or measure parts of the clotting process. The analyzer detects clot formation or related signal changes using optical, mechanical, electrochemical, or other methods. It then reports a value such as clotting time, ratio, concentration, or calculated result. Quality control and calibration help confirm that the instrument and reagents are performing correctly.
Coagulation analyzers can be small point-of-care units, benchtop analyzers, or high-throughput laboratory systems. Some are designed for PT and INR testing, while others run broader panels. Automated systems may handle sample loading, reagent mixing, detection, and result reporting. The right analyzer depends on testing volume, turnaround time, accuracy needs, and laboratory workflow.
Coagulation results can be affected by sample collection, tube fill level, anticoagulant ratio, clots in the tube, hemolysis, delayed testing, reagent storage, and instrument maintenance. Medication use, liver disease, vitamin K status, and clotting factor problems can also affect results. Unexpected results may need repeat testing or confirmation. Active bleeding, stroke symptoms, chest pain, or signs of a clot require urgent medical attention rather than waiting on routine testing.
It may run PT, INR, aPTT, fibrinogen, D-dimer, thrombin time, or other clotting tests depending on the device and reagents.
No. It can be used in hospitals, reference labs, clinics, anticoagulation services, and some point-of-care settings.
Yes. PT and INR testing are commonly used to monitor warfarin therapy when ordered by a clinician.
Yes. Sample problems, reagent issues, device errors, or patient factors can affect results. Quality control and clinical review are important.
Interpretation of Blood Clotting Studies and Values. StatPearls (NCBI Bookshelf). https://www.ncbi.nlm.nih.gov/books/NBK604215/. Date Accessed June 18, 2026.
Prothrombin Time. StatPearls (NCBI Bookshelf). https://www.ncbi.nlm.nih.gov/books/NBK544269/. Date Accessed June 18, 2026.
Prothrombin Time Test and INR (PT/INR). MedlinePlus. https://medlineplus.gov/lab-tests/prothrombin-time-test-and-inr-ptinr/. Date Accessed June 18, 2026.
Partial Thromboplastin Time (PTT) Test. MedlinePlus. https://medlineplus.gov/lab-tests/partial-thromboplastin-time-ptt-test/. Date Accessed June 18, 2026.
Coagulation analyzer: Product Classification. U.S. Food and Drug Administration. https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpcd/classification.cfm?id=GKP. Date Accessed June 18, 2026.